Next-generation sequencing based detection of HER2 copy number predicts pathological response to neoadjuvant therapy in HER2 positive breast cancer

被引：0
作者：
Dai, Hao
Jiao, Dechuang
Guo, Xuhui
Qiao, Jianghua
Li, Anfang
Lu, Zhenduo
Chen, Xiuchun
Wang, Chengzheng
Yan, Min
Liu, Zhenzhen
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6439
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6439
引用
收藏
页数：2
相关论文
共 50 条
[11]   Complete pathological response in patients with HER2 positive breast cancer treated with neoadjuvant therapy in Colombia [J].
Rodriguez, Mauricio ;
Gonzalez, Diego M. ;
El-Sharkawy, Farah ;
Castano, Mileny ;
Madrid, Jorge .
BIOMEDICA, 2023, 43 (03) :396-405
[12]   Evaluation of next generation sequencing for detecting HER2 copy number in breast and gastric cancers. [J].
Lin, Dongmei ;
Ji, Jiafu ;
Niu, Dongfeng ;
Li, Lei ;
Yu, Yang ;
Gao, Yun ;
Zhang, Wanchun ;
Li, Zhongwu ;
Rao, Guanhua ;
Gao, Lianju ;
Cheng, Gang .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[13]   The Relationship of HER2 Copy Number Evaluated by Brightfield Dual In Situ Hybridisation DNA Assay and Pathologic Response to Neoadjuvant Treatment in HER2 Positive Breast Cancer [J].
Neville, G. ;
Feeley, L. ;
Bennett, M. W. ;
O'Reilly, S. ;
Corrigan, M. ;
O'Connell, F. ;
Browne, T. J. .
JOURNAL OF PATHOLOGY, 2017, 243 :S22-S22
[14]   Clinical Utility of HER2/ERBB2 Copy Number Analysis by Next Generation Sequencing in Metastatic Breast Cancer [J].
Xia, Daniel ;
Kuo, Frank ;
Dillon, Deborah .
MODERN PATHOLOGY, 2018, 31 :113-113
[15]   Clinical Utility of HER2/ERBB2 Copy Number Analysis by Next Generation Sequencing in Metastatic Breast Cancer [J].
Xia, Daniel ;
Kuo, Frank ;
Dillon, Deborah .
LABORATORY INVESTIGATION, 2018, 98 :113-113
[16]   Next-generation sequencing based deep learning model for prediction of HER2 status and response to HER2-targeted neoadjuvant chemotherapy [J].
Wang, Jia ;
Gao, Ge ;
Tian, Cong ;
Zhang, Jiao ;
Jiao, De-Chuang ;
Liu, Zhen-Zhen .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2025, 151 (02)
[17]   Percentage of HER2 immunohistochemistry complete membrane staining is not significantly associated with response to neoadjuvant therapy in HER2 positive breast cancer [J].
Li, Xiaoxian ;
Zhao, Jing ;
Zhang, Chao ;
Li, Zaibo .
MODERN PATHOLOGY, 2019, 32
[18]   Predictive Value of HER2 Fluorescence In Situ Hybridization (FISH) Result in HER2 Positive Breast Cancer Response to Neoadjuvant Therapy [J].
Zhao, Jing ;
Suo, Aili ;
Zhang, Chao ;
Shi, Quiying ;
Wei, Zhimin ;
Li, Zaibo ;
Li, Xiaoxian .
MODERN PATHOLOGY, 2019, 32
[19]   Percentage of HER2 immunohistochemistry complete membrane staining is not significantly associated with response to neoadjuvant therapy in HER2 positive breast cancer [J].
Li, Xiaoxian ;
Zhao, Jing ;
Zhang, Chao ;
Li, Zaibo .
LABORATORY INVESTIGATION, 2019, 99
[20]   Predictive Value of HER2 Fluorescence In Situ Hybridization (FISH) Result in HER2 Positive Breast Cancer Response to Neoadjuvant Therapy [J].
Zhao, Jing ;
Suo, Aili ;
Zhang, Chao ;
Shi, Qiuying ;
Wei, Zhimin ;
Li, Zaibo ;
Li, Xiaoxian .
LABORATORY INVESTIGATION, 2019, 99
12345